Systemic carboplatin for retinoblastoma: change in tumour size over time

Background/aim: Chemotherapy for intraocular retinoblastoma is used to shrink individual retinal tumours to a size amenable to focal treatments. Quantitative data regarding retinal tumour response following treatment with primary systemic carboplatin are reported. Methods: Changes in area and larges...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Abramson, D H, Lawrence, S D, Beaverson, K L, Lee, T C, Rollins, I S, Dunkel, I J
Formato: Artigo
Lenguaje:Inglês
Publicado: Copyright 2005 British Journal of Ophthalmology 2005
Materias:
Clinical Science - Extended Reports
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1772963/
https://ncbi.nlm.nih.gov/pubmed/16299142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2005.072033
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares